Back to feed
DYNDyne Therapeutics, Inc.
CIK 0001818794 · last filing 2d ago · 10 insider transactions
Buy volume
$0
0 buy transactions
Sell volume
$5.69M
10 sell transactions
Net flow
-$5.69M
Net selling
Total flow
$5.69M
10 priced transactions
Disclosure radarcross-source convergence
Institution-led3/5 sources
4/100
Recent disclosures · timeline
- Form 42d ago
Director · sold $5.65M
- Form 42d ago
Chief Financial Officer · sold $48.1K
- Form 1443d ago
Proposed sale of 2,362 sh ($48.1K) · discretionary
Price · DYN
Live chart by TradingViewLive chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
DYN insider flow· last 30 days
Buys Sellsnet -$5.69M
Institutional holders · 13F
Q1 2026 vs Q4 2025 · live SEC data7 funds hold$729.84M reported valueNet reducing(4 adding · 4 reducing)
| Fund | Shares | Value | % of portfolio | QoQ |
|---|---|---|---|---|
| Vanguard Group Inc | 11,215,565 | $219.38M | 0.0% | Add+15% |
| BlackRock Inc | 11,699,870 | $212.12M | 0.0% | Add+5% |
| FMR LLC (Fidelity) | 8,908,980 | $161.52M | 0.0% | Add |
Proposed sales · Form 144
selling intent · live SEC data1 notice$48.1K proposed to sell0/1 under a 10b5-1 plan
| Filed | Filer | Shares | Est. value | Approx. sale | Source of shares | Plan |
|---|---|---|---|---|---|---|
| 3d ago | Lucera Erick Officer | 2,362 | $48.1K | Jun 25, 2026 | Restricted Stock Units | Discretionary |
Recent insider transactions
| Filed | Insider | Transaction | Shares | Price | Value | Signal | Flags | |
|---|---|---|---|---|---|---|---|---|
2d ago Jun 25, 2026 | Rhodes Jason P Director | Sell · S | 5,019 | $21.10 | $105.9K | Mild sell-19 | 10b5-1 Late | |
2d ago Jun 25, 2026 | Rhodes Jason P Director | Sell · S | 6,382 | $21.10 | $134.7K | Mild sell-19 | 10b5-1 Late | |
2d ago Jun 25, 2026 | Rhodes Jason P Director | Sell · S | 12,699 | $21.10 | $267.9K | Mild sell-19 | 10b5-1 Late | |
2d ago Jun 24, 2026 | Rhodes Jason P Director | Sell · S | 50,530 | $21.02 | $1.06M | Mild sell-19 | 10b5-1 Late | |
2d ago Jun 24, 2026 | Rhodes Jason P Director | Sell · S | 25,397 | $21.02 | $533.8K | Mild sell-19 | 10b5-1 Late | |
2d ago Jun 24, 2026 | Rhodes Jason P Director | Sell · S | 19,973 | $21.02 | $419.8K | Mild sell-19 | 10b5-1 Late | |
2d ago Jun 23, 2026 | Rhodes Jason P Director | Sell · S | 77,855 | $21.13 | $1.65M | Mild sell-19 | 10b5-1 Late | |
2d ago Jun 23, 2026 | Rhodes Jason P Director | Sell · S | 39,131 | $21.13 | $826.8K | Mild sell-19 | 10b5-1 Late | |
2d ago Jun 23, 2026 | Rhodes Jason P Director | Sell · S | 30,774 | $21.13 | $650.3K | Mild sell-19 | 10b5-1 Late | |
2d ago Jun 25, 2026 | Lucera Erick Chief Financial Officer | Sell · S | 2,362 | $20.37 | $48.1K | Neutral-7 |